US FDA’s Drugs, Biologics Centers See Increased Hiring, But Not Enough To Overcome Departures

Hiring increased at the FDA in the FY 2026 first quarter, but was outnumbered by departures. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from United States